<DOC>
	<DOCNO>NCT00420056</DOCNO>
	<brief_summary>This pilot study evaluate tumor activity use Positron Emission Tomography , also know `` PET scan '' . This study ass safety use PD-0332991 patient mantle cell lymphoma .</brief_summary>
	<brief_title>An Investigational Study Drug , Palbociclib ( PD-0332991 ) , Is Being Studied In Patients With Mantle Cell Lymphoma . Patients Must Have Received Prior Treatment ( ) For Mantle Cell Lymphoma .</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Mantle-Cell</mesh_term>
	<mesh_term>Palbociclib</mesh_term>
	<criteria>Histologically document MCL . Must receive least one prior therapy . Eastern Cooperative Oncology Group ( ECOG ) performance status â‰¤1 . Adequate organ function outline protocol . Major surgery , radiation therapy , systemic therapy within 4 week study enrollment . Prior radiation therapy &gt; 25 % bone marrow ( whole pelvis 25 % ) . Uncontrolled brain metastasis , spinal cord compression , carcinomatous meningitis , leptomeningeal disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>